BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 124 filers reported holding BLUEBIRD BIO INC in Q3 2014. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,660,000 | -40.7% | 64,500 | -14.0% | 0.47% | -64.3% |
| Q2 2019 | $9,540,000 | -27.6% | 75,000 | -10.5% | 1.30% | +8.5% |
| Q1 2019 | $13,184,000 | -4.2% | 83,796 | -39.6% | 1.20% | -22.5% |
| Q4 2018 | $13,769,000 | +20.3% | 138,796 | +77.0% | 1.55% | +18.1% |
| Q3 2018 | $11,446,000 | +0.6% | 78,396 | +8.2% | 1.31% | -16.2% |
| Q2 2018 | $11,376,000 | +556.8% | 72,483 | +81.2% | 1.57% | +248.4% |
| Q2 2016 | $1,732,000 | +35.8% | 40,000 | +33.3% | 0.45% | +63.0% |
| Q1 2016 | $1,275,000 | -33.5% | 30,000 | -43.8% | 0.28% | +16.5% |
| Q3 2014 | $1,916,000 | +46.7% | 53,405 | -7.0% | 0.24% | -20.5% |
| Q1 2014 | $1,306,000 | -32.6% | 57,435 | -37.9% | 0.30% | -44.8% |
| Q4 2013 | $1,939,000 | – | 92,435 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |